title: The year in gout: 2011-2012.
abstract: From an epidemiologic view, gout is an increasingly prevalent and increasingly pressing clinical problem. This fact, together with technical advances in biology, pharmacology, and imaging techniques, have led to a decade of increasingly rapid progress in our collective understanding of gout and hyperuricemia. Here we review some of the most important recent advances in gout over the past 12 to 18 months.
authors.affiliation: Division of Rheumatology, NYU Hospital for Joint Diseases, New York, NY 10003, USA.
authors.forename: Daria B
authors.initials: DB
authors.lastname: Crittenden
authors.forename: Michael H
authors.initials: MH
authors.lastname: Pillinger
mesh_terms: D000818:Animals; D015897:Comorbidity; D006073:Gout / Q000175:diagnosis / Q000178:diet therapy / Q000188:drug therapy / Q000453:epidemiology; D006074:Gout Suppressants / Q000627:therapeutic use; D006801:Humans; D033461:Hyperuricemia / Q000175:diagnosis / Q000178:diet therapy / Q000188:drug therapy / Q000453:epidemiology; D010003:Osteoarthritis / Q000453:epidemiology; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012307:Risk Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D006074:Gout Suppressants